MULTI-ISSUER PROGRAMME 4 (RF) LIMITED - Subscription for shares in Al Noor by REMGRO and RMB standby Liquidity Facility - MIP4C, MIP4F

Subscription for shares in Al Noor by REMGRO and RMB standby Liquidity Facility - MIP4C, MIP4F

Multi-Issuer Programme 4 (RF) Limited
Incorporated in the Republic of South Africa
Registration No. 2015/060259/06)
Company code: MUPI
(“MIP4”)

SUBSCRIPTION FOR SHARES IN AL NOOR BY REMGRO AND RMB STANDBY
LIQUIDITY FACILITY

MIP4 wishes to refer noteholders to the Stock Exchange News
Service announcement released by Remgro Limited (“Remgro”)
today, 14 October 2015, advising of Remgro’s intention to
subscribe for 72,115,384 shares in Al Noor Hospitals Group plc
(“Al Noor”) for an aggregate subscription amount of
GBP600 million (“Remgro Subscription”).

The Remgro Subscription forms part of a larger transaction
whereby Al Noor will offer to acquire 100% of the issued share
capital of Mediclinic International Limited (“Mediclinic”) by
way of a scheme of arrangement in terms of section 114 of the
South African Companies Act 71 of 2008 (“Mediclinic Scheme”).

It is expected that related shareholder meetings of both
Mediclinic and Al Noor will be held during December 2015 and
that the Mediclinic Scheme will be implemented during the
first quarter of 2016.

In order to proceed with the Remgro Subscription, Remgro was
required to obtain a standby liquidity facility equal to the
final redemption value of the outstanding notes issued by
MIP4.

Rand Merchant Bank, a division of FirstRand Bank Limited
(“RMB”) arranged a R3.5 billion standby liquidity facility
specifically earmarked for the repayment of the outstanding
notes issued by MIP4 and guaranteed by Remgro, which notes
mature on 13 January 2016.

For further information, please contact Dassen Naidoo on 011
269 9075.

14 October 2015

Debt Sponsor
Rand Merchant Bank (A division of FirstRand Bank Limited)

Date: 14/10/2015 08:02:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.